none
Want to Start a Business? … Need Help With Digital Marketing? We Build & Grow Businesses For Female Entrepreneurs.

Startups should look to state-of-the-art tech to tackle diseases affecting women

Shahar Keinan Contributor

Pek Lum Contributor

Pek Lum, co-founder and CEO at Auransa, has more than 20 years of genomics and drug discovery experience and is the chief architect behind Auransa’s technology.

Startups devoted to reproductive and women’s health are on the rise. However, most of them deal with women’s fertility: birth control, ovulation and the inability to conceive. The broader field of women’s health remains neglected.

Historically, most of our understanding of ailments comes from the perspective of men and is overwhelmingly based on studies using male patients. Until the early 1990s, women of childbearing age were kept out of drug trial studies, and the resulting bias has been an ongoing issue in healthcare. Other issues include underrepresentation of women in health studies, trivialization of women’s physical complaints (which is relevant to the misdiagnosis of endometriosis, among other conditions), and gender bias in the funding of research, especially in research grants.

For example, several studies have shown that when we look at National Institutes of Health funding, a disproportionate share of its resources goes to diseases that primarily affect men — at the expense

. . .

This story was published at TechCrunch.com (kw:women,female) and provided for your interest.

SHARE

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on reddit
Reddit
Share on email
Email

Join over 10,000 female entrepreneurs who read our curated weekly briefs.

Join over 10,000 female entrepreneurs who read Boss Ladies Mindset curated weekly briefs.

We respect your privacy | Privacy Policy | Terms